Barclays Upgrades Copa Holdings to Overweight

Barclays analyst Pablo Monsivais upgrades Copa Holdings (NYSE:CPA) from Underweight to Overweight.

Barclays analyst Pablo Monsivais upgrades Copa Holdings (NYSE:CPA) from Underweight to Overweight.

Total
0
Shares
Related Posts
Read More

Xencor To Report Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors At Annual Meeting of the American Society of Clinical Oncology On June 5

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported initial dose-escalation data from

XNCR